/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.
The phase I clinical trial of the COVID-19 mRNA vaccine developed by a Shanghai-based biotechnology firm has completed patient enrollment in China, according to a report by online news portal ThePaper.cn.